Syngenta to Acquire Pasteuria Bioscience and 4 Stocks Hitting 52-Week Highs
Sprint Nextel Corp. (NYSE:S): Samsung (SSNLF) is to release the Galaxy Note II, which is a smartphone/tablet hybrid, in the U.S. with five major carriers by the middle of November, according to the company. The device should be available for the holidays with AT&T (NYSE:T), Sprint (NYSE:S), Deutsche Telekom’s (DTEGY) T-Mobile, Verizon Wireless (VZ,VOD) and U.S. Cellular (NYSE:USM). The company has also stated that the pricing and retail availability is to be announced by each of the carriers. The shares closed at $5.56, up $0.37 or 7.13% on the day. They have traded in a 52-week range of $2.10 to $5.49.
Don’t Miss: Spotlight: RIM’s Fight for Mobile Market Share.
Syngenta Ag (NYSE:SYT) has agreed to acquire Pasteuria Bioscience, Inc., and since 2011 Syngenta and Pasteuria have had an exclusive global technology partnership for the development and commercialization of biological products for the control plant-parasitic nematodes, by the use of the natural soil bacteria called Pasteuria spp. An innovative in-vitro production process should allow the cost-effective nematicides with a novel mode of action to be developed. A seed treatment intended for soybean cyst nematode is the first product to be launched in the USA during 2014. Beneath the terms of the agreement, Syngenta is to acquire Pasteuria Bioscience for aggregate payments of $86 million, along with deferred payments costing as much as $27 million. The transaction should close during Q4 of 2012. The shares closed at $74.11, up $0.6 or 0.82% on the day. They have traded in a 52-week range of $49.13 to $74.23.
Tekmira Pharmaceutic (NASDAQ:TKMR) has given a n update to its shareholders regarding the continued litigation with Alnylam Pharmaceuticals (NASDAQ:AMLN) and AlCana Technologies. CEO Dr. Mark J. Murray stated: “We are firmly committed to regaining control of our LNP technology and preserve its full value for Tekmira. The Massachusetts Superior Court has issued a pre-trial scheduling order with the timeline for the remaining pre-trial events leading up to a trial commencing on Nov. 14, 2012.” The shares closed at $3.80, up $0.17 or 4.68% on the day. They have traded in a 52-week range of $1.29 to $3.88.
Time Warner Inc. (NYSE:TWX): News Corp.’s (NASDAQ:NWSA) Fox is now leading the competition in securing a new broadcast rights deal with Major League Baseball, The New York Post reports. Comcast’s (NASDAQ:CMCSA) NBC’s bid was short and CBS (NYSE:CBS) no longer wishes to make a joint bid with Time Warner-owned (NYSE:TWX) Turner Sports. The shares closed at $45.51, up $0.64 or 1.43% on the day. They have traded in a 52-week range of $28.26 to $45.07.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>